Further evidence revealed that miR-10a-5p targets matrix metallopeptidase 14 (MMP14) and actin gamma 1 (ACTG1), both of which positively regulate BCL-2 levels and render cancer cells resistant to anoikis in colorectal cancer cells [125] (Figure 2 and Table 2). Here, MMP14 is linked to cancer.